Neo Ivy Capital Management Repligen Corp Transaction History
Neo Ivy Capital Management
- $293 Million
- Q1 2025
A detailed history of Neo Ivy Capital Management transactions in Repligen Corp stock. As of the latest transaction made, Neo Ivy Capital Management holds 16,436 shares of RGEN stock, worth $2.4 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
16,436Holding current value
$2.4 Million% of portfolio
0.71%Shares
13 transactions
Others Institutions Holding RGEN
# of Institutions
506Shares Held
58.7MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$964 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$741 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$279 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$237 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.1B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....